Abstract:Case summary: A 7-month-old domestic shorthair cat was presented for evaluation of stunted growth, recurrent hypoglycaemia during the first months of its life and altered mentation. Complete blood count and biochemistry were unremarkable, except for mildly elevated serum creatinine concentration (despite low muscle mass) and concurrent isosthenuria. Hyposomatotropism was diagnosed based on persistent low circulating insulin-like growth factor 1 concentrations and a lack of response of circulating growth hormone (GH) concentration after the administration of GH-releasing hormone. Other endocrinopathies such as hypothyroidism and hypoadrenocorticism were excluded. MRI of the brain revealed a fluid-filled empty sella tursica, consistent with a pituitary cyst and atrophy/hypoplasia of the pituitary. Echocardiography was unremarkable at the time of diagnosis of hyposomatotropism. Three months later, ovariohysterectomy revealed immature ovaries, raising the suspicion of luteinising and follicle-stimulating hormone deficiency. At 1 year of age, the cat developed congestive heart failure secondarily to dilated cardiomyopathy (DCM) with severely reduced left ventricular systolic function and died a few days later. Pathology showed atrophy of the adenohypophysis, epithelial delineation of the pituitary cysts, mild cardiomegaly, multifocal fibrosis of the left ventricle and a mild, multifocal, chronic epicarditis. Relevance and novel information: GH deficiency is a very rare endocrinopathy in cats. This is the first case to describe the development of DCM with concurrent hyposomatotropism, which has previously been reported in human medicine. Other notable abnormalities that could be related to GH deficiency are juvenile self-limiting hypoglycaemia, behavioural changes and possible nephropathy.

Dihydropyrimidinase deficiency: the first feline case of dihydropyrimidinuria with clinical and molecular findings

A case of dihydropyrimidinase deficiency incidentally detected by urine metabolome analysis

Dihydropyrimidinase deficiency: structural organization, chromosomal localization, and mutation analysis of the human dihydropyrimidinase gene

Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity

Dihydropyrimidinase deficiency: Phenotype, genotype and structural consequences in 17 patients

First report of HGD mutations in a Chinese with alkaptonuria.

Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiency

The diagnostic odyssey of a patient with dihydropyrimidinase deficiency: a case report and review of the literature

Dilated cardiomyopathy in a cat with congenital hyposomatotropism

Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity

A novel stop-gain mutation in DPYS gene causing Dihidropyrimidinase deficiency, a case report

Diagnosis of dihydropyrimidinase deficiency in a Chinese boy with dihydropyrimidinuria

Rapid gas chromatographic-mass spectrometric diagnosis of dihydropyrimidine dehydrogenase deficiency and dihydropyrimidinase deficiency

Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene

Dihydropyrimidinase deficiency with atrioventricular septal defect: a case report

EDA Missense Variant in a Cat with X-Linked Hypohidrotic Ectodermal Dysplasia

Dihydropyrimidinase deficiency, a progressive neurological disorder?

Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity

Identification and Functional Characterization of a Novel Homozygous Intronic Variant in the Fumarylacetoacetate Hydrolase Gene in a Chinese Patient with Tyrosinemia Type 1.

Dihydropyrimidinase enzyme deficiency and congenital isolated adrenocorticotrophin deficiency: dual genetic diagnosis in a Sri Lankan boy

Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation?